[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354110-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354110-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nlrx1-drives-prostate-cancer-progression-through-activation-of-akt-and-erk-signaling-pathways-research-paper","NLRX1 Drives Prostate Cancer Progression Through Activation of AKT and ERK Signaling Pathways - Research Paper","","NLRX1, a mitochondrial NOD-like receptor protein, functions as a non-inflammasome-forming regulator with context-dependent effects in cancer. This study investigates its role in prostate cancer by assessing proliferation, apoptosis, migration, invasion, and tumor progression, alongside molecular signaling changes. TCGA analysis connects NLRX1 expression with prognosis, and serum-free stress upregulates NLRX1. NLRX1 depletion impairs proliferation in PC3, blocks migration and invasion, and promotes apoptosis under serum-free conditions, linked to reduced AKT and ERK phosphorylation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nlrx1-drives-prostate-cancer-progression-through-activation-of-akt-and-erk-signaling-pathways-research-paper/354110/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nlrx1-drives-prostate-cancer-progression-through-activation-of-akt-and-erk-signaling-pathways-research-paper/354110.png","ImageObject",300,407,{"name":42,"@type":43},"Bintang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study on NLRX1 in prostate cancer?","Question",{"text":63,"@type":64},"The study evaluates how NLRX1 influences prostate cancer cell proliferation, apoptosis, migration, invasion, and overall tumor progression, including the signaling mechanisms involved.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does NLRX1 expression change under serum-free stress conditions?",{"text":68,"@type":64},"NLRX1 expression is upregulated under serum-free stress conditions, indicating it responds to nutrient deprivation.",{"name":70,"@type":61,"acceptedAnswer":71},"Which signaling pathway changes are linked to NLRX1 knockdown?",{"text":72,"@type":64},"Mechanistic results show NLRX1 knockdown reduces AKT and ERK phosphorylation in response to serum deprivation, EGF, and TGF-β, while PDK1 activity under serum deprivation is not affected.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354110,1790528174,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2026; 22(8): 4417-4440. doi: 10.7150/ijbs.126054  \nResearch Paper  \nNLRX1 Drives Prostate Cancer Progression Through Activation of AKT and ERK Signaling Pathways  \nVarsha Rathore1,2,3, Ching-Yuan Cheng3, Duen-Yi Huang3, Shao-Peng Chen3, Liang Huan Wu3,4, Jitendra Maharana1,5, Chuang-Rung Chang2, Wan-Wan Lin3,6􀀍  \n1. Chemical Biology and Molecular Biophysics, Taiwan International Graduate Program, Academia Sinica, Taipei 115201, Taiwan.  \n2. Institute of Biotechnology, College of Life Sciences and Medicine, National Tsing Hua University, Hsinchu 300044, Taiwan.  \n3. Department of Pharmacology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan.  \n4. Department of Ophthalmology, Cardinal Tien Hospital, New Taipei City 23148, Taiwan.  \n5. Institute of Bioinformatics and Structural Biology, College of Life Sciences and Medicine, National Tsing Hua University, Hsinchu 300044, Taiwan.  \n6. Graduate Institute of Medical Sciences, Taipei Medical University, Taipei 110, Taiwan.  \n􀀍 Corresponding author: Wan-Wan Lin, PhD, Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan. Tel:  \n(02)23123456\\#288315; [E-mail: wwllaura1119@ntu.edu.tw](E-mail: wwllaura1119@ntu.edu.tw).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.09.29; Accepted: 2026.03.31; Published: 2026.04.16  \nAbstract  \nNLRX1, a mitochondrial NOD-like receptor (NLR) family protein, is a non-inflammasome-forming protein with diverse roles in cancer. While NLRX1 has been recognized as a tumor suppressor in colorectal and hepatocellular carcinomas, it appears to act as a tumor promoter in breast and head and neck cancers. This study explored the role of NLRX1 in prostate cancer (PCa), examining its impact on cell proliferation, apoptosis, migration, invasion, and tumor progression, as well as associated molecular mechanisms. Using TCGA data, the association between NLRX1 expression and PCa prognosis was evaluated. NLRX1 expression was upregulated under serum-free stress conditions. Silencing NLRX1 reduced cell proliferation in PC3 cells, but not in LNCaP cells. Additionally, NLRX1 knockdown inhibited migration and invasion, while promoting apoptosis under serum-free conditions. Mechanistically, NLRX1 knockdown reduced AKT and ERK phosphorylationin response to serum deprivation, EGF, and TGF-β, without affecting PDK1 activity under serum deprivation. Pharmacological data showed AKT and ERK as key regulators of viability and invasion, with AKT critical for growth and migration. Co-immunoprecipitation, confocal microscopic examination, domain binding, structural modeling, and molecular dynamics revealed a stable interaction between NLRX1’s LRR domain and AKT’s PH domain. NLRX1 facilitated cell proliferation, migration, invasion, and resistance to serum-free stress through direct interaction with AKT, highlighting NLRX1 as a promising biomarker for PCa progression.  \nKeywords: Prostate cancer; NLRX1; AKT; Apoptosis; Invasion; Migration  \nIntroduction  \nNOD-like receptor X1 (NLRX1), often called NOD5, NOD9, and CLR11 .3, is a member of the NOD-like receptor family. Like other NLRs, NLRX1 contains a central NACHT domain that mediates nucleotide binding and oligomerization, supporting its role as a scaffolding protein, as well as a C-terminal LRR domain. In addition, the first 39 amino acids atthe N-terminus of NLRX1 comprise a unique and unconventional mitochondrial targeting sequence [1] . Of all the NOD-like receptors, NLRX1 is the only one  \nthat targets the mitochondria [2] and is located in the outer mitochondrial membrane [1], inner mitochondrial membrane [3], and ","cbCaiuaraD7Ijoid","https://ap.wps.com/l/cbCaiuaraD7Ijoid","pdf",10245751,24,"English","# Abstract\n# Introduction\n## NLRX1 biology and mitochondrial targeting\n## NLRX1 roles in cancer and immune signaling","[{\"question\":\"What is the main focus of the study on NLRX1 in prostate cancer?\",\"answer\":\"The study evaluates how NLRX1 influences prostate cancer cell proliferation, apoptosis, migration, invasion, and overall tumor progression, including the signaling mechanisms involved.\"},{\"question\":\"How does NLRX1 expression change under serum-free stress conditions?\",\"answer\":\"NLRX1 expression is upregulated under serum-free stress conditions, indicating it responds to nutrient deprivation.\"},{\"question\":\"Which signaling pathway changes are linked to NLRX1 knockdown?\",\"answer\":\"Mechanistic results show NLRX1 knockdown reduces AKT and ERK phosphorylation in response to serum deprivation, EGF, and TGF-β, while PDK1 activity under serum deprivation is not affected.\"}]","NLRX1 Drives Prostate Cancer Progression Through Activation of AKT and ERK Signaling Pathways - Research Paper | PDF",1790109005,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68f25ae5b40a8392c257274ce5fb2dcf.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e1288cb0dd3ee8a8b7f688e54dcb563.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d7c4c02bd94a0e3c11acfb7bc828775.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af4ac895503d1ed54a75e4cf8de11ead.webp",980,1268]